title: Clinical trials for pediatric MS should be prioritized to test only one or two of the most promising agents - YES.
authors.affiliation: The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, USA banwellb@email.chop.edu.
authors.forename: Brenda
authors.initials: B
authors.lastname: Banwell
mesh_terms: D002648:Child; D002986:Clinical Trials as Topic; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000188:drug therapy* / Q000628:therapy; D010372:Pediatrics
chemical_list: D007155:Immunologic Factors